Stay updated on Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No study content or user-facing information appears to be altered.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 is displayed, replacing v3.4.1; no study content, endpoints, or navigation were altered.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. All study content, links, and instructions appear unchanged.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing Florida, Iowa, Minnesota, Nebraska, Oregon, and Pennsylvania. Updated the revision to v3.3.3 and removed the prior separate location sections (Florida Locations, Iowa Locations, Minnesota Locations, Nebraska Locations, Oregon Locations, Pennsylvania Locations) along with the HHS Vulnerability Disclosure link.SummaryDifference0.7%

- Check106 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.3.1 has been removed.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.